# US 2021/0071245 A1 · Dna amplification technology

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0071245 A1
- Document ID: US20210071245A1
- Status: Published application
- Kind: A1
- Application number: 16/855,776
- Filed: 2020-04-22
- Published: 2021-03-11
- Earliest claimed: 2014-07-10
- Applicants: XCR Diagnostics, Inc.
- Inventors: Brian CAPLIN; Bryson Green
- Web page: https://patentgrep.com/patent/US20210071245A1

## CPC

- C12Q 1/6846: {Common amplification features}
- C12Q 1/6853: using modified primers or templates
- C12Q 1/6811: Selection methods for production or design of target specific oligonucleotides or binding molecules
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/689: for bacteria
- C12Q 2525/301: Hairpin oligonucleotides
- C12Q 2527/107: Temperature of melting, i.e. Tm
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods and reagents suitable for conducing polymerase chain reaction are described. In particular, a nucleic acid amplification design strategy and thermal cycling profile to enable efficient amplification of multiple nucleic acid targets along with improved sensitivity is disclosed. The present disclosure also describes methods and devices for increasing the melting temperature (Tm) of a primer.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A method for increasing the melting temperature (Tm) of an oligonucleotide primer for amplification of a target nucleic acid sequence in a polymerase chain reaction (PCR), comprising:
identifying a target nucleic acid sequence on a first strand of a double-stranded target nucleic acid;
designing an oligonucleotide primer comprising a 3′ end having substantially complementary to a binding site at the 5′ end of the target nucleic acid sequence on the first strand of the target nucleic acid, and a 5′ end substantially complementary to a binding site on the second strand of the target nucleic acid opposite to the binding site of the 3′ end of the first oligonucleotide primer; and
wherein the Tm of the oligonucleotide primer is increased compared to the Tm of an oligonucleotide primer having only the first region.

### Claim 23 (depends on 22)

The method of claim 22, wherein the Tm of the oligonucleotide primer is within at least 15° C. of the Tm of the target nucleic acid sequence.

### Claim 24 (depends on 22)

The method of claim 22, wherein the Tm of the oligonucleotide primer is within at least 10° C. of the Tm of the target nucleic acid sequence.

### Claim 25 (depends on 22)

The method of claim 22, wherein the Tm of the oligonucleotide primer is within at least 5° C. of the Tm of the target nucleic acid sequence.

### Claim 26 (depends on 22)

The method of claim 22, wherein the Tm of the oligonucleotide primer is within at least 2.5° C. of the Tm of the target nucleic acid sequence.

### Claim 27 (depends on 22)

The method of claim 22, wherein the Tm of the oligonucleotide primer is approximately equal to the Tm of the target nucleic acid sequence.

### Claim at position 8

28-79. (canceled)
